HIGH-DOSE CYTOSINE-ARABINOSIDE - PHARMACOLOGICAL AND CLINICAL ASPECTS

被引:44
作者
PETERS, WG
COLLY, LP
WILLEMZE, R
机构
来源
BLUT | 1988年 / 56卷 / 01期
关键词
D O I
10.1007/BF00321053
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1 / 11
页数:11
相关论文
共 97 条
  • [71] PETERS WG, 1986, SCAND J HAEMATOL, V36, P7
  • [72] PETERS WG, 1987, SEMIN ONCOL, V14, P86
  • [73] PALMAR-PLANTAR SKIN CHANGES AND CYTARABINE
    PETERS, WG
    WILLEMZE, R
    [J]. ANNALS OF INTERNAL MEDICINE, 1985, 103 (05) : 805 - 805
  • [74] PLAGEMANN PGW, 1978, CANCER RES, V38, P978
  • [75] PLUNKETT W, 1982, P AN M AM SOC CLIN, V1, P31
  • [76] PERIPHERAL NEUROPATHY AFTER HIGH-DOSE CYTOSINE-ARABINOSIDE, DAUNORUBICIN, AND ASPARAGINASE CONSOLIDATION FOR ACUTE NONLYMPHOCYTIC LEUKEMIA
    POWELL, BL
    CAPIZZI, RL
    LYERLY, ES
    COOPER, MR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (01) : 95 - 97
  • [77] PRENTICE HG, 1986, CLIN HAEMATOL, V15, P755
  • [78] RICHARDS MA, 1985, SEMIN ONCOL, V12, P223
  • [79] RITCH PS, 1983, CANCER, V51, P430, DOI 10.1002/1097-0142(19830201)51:3<430::AID-CNCR2820510313>3.0.CO
  • [80] 2-5